Kanada - Englisch - Health Canada

sandoz canada incorporated - pemetrexed (pemetrexed disodium hemipentahydrate) - powder for solution - 100mg - pemetrexed (pemetrexed disodium hemipentahydrate) 100mg - antineoplastic agents

Kanada - Englisch - Health Canada

sandoz canada incorporated - pemetrexed (pemetrexed disodium hemipentahydrate) - powder for solution - 500mg - pemetrexed (pemetrexed disodium hemipentahydrate) 500mg - antineoplastic agents

Kanada - Englisch - Health Canada

sandoz canada incorporated - pemetrexed (pemetrexed disodium hemipentahydrate) - powder for solution - 1000mg - pemetrexed (pemetrexed disodium hemipentahydrate) 1000mg - antineoplastic agents

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - pemetrexed disodium hemipentahydrate, quantity: 604.1 mg (equivalent: pemetrexed, qty 500 mg) - injection, concentrated - excipient ingredients: trometamol; hydrochloric acid; sodium hydroxide; water for injections; monothioglycerol; citric acid - malignant pleural mesothelioma,pemetrexed ever pharma, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer,pemetrexed ever pharma in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,pemetrexed ever pharma as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - pemetrexed disodium hemipentahydrate, quantity: 1208.21 mg (equivalent: pemetrexed, qty 1000 mg) - injection, concentrated - excipient ingredients: trometamol; hydrochloric acid; sodium hydroxide; water for injections; monothioglycerol; citric acid - malignant pleural mesothelioma,pemetrexed ever pharma, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer,pemetrexed ever pharma in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,pemetrexed ever pharma as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - pemetrexed disodium hemipentahydrate, quantity: 120.82 mg (equivalent: pemetrexed, qty 100 mg) - injection, concentrated - excipient ingredients: trometamol; hydrochloric acid; sodium hydroxide; water for injections; monothioglycerol; citric acid - malignant pleural mesothelioma,pemetrexed ever pharma, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer,pemetrexed ever pharma in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,pemetrexed ever pharma as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Kanada - Englisch - Health Canada

marcan pharmaceuticals inc - pemetrexed (pemetrexed disodium hemipentahydrate) - powder for solution - 100mg - pemetrexed (pemetrexed disodium hemipentahydrate) 100mg - antineoplastic agents

Kanada - Englisch - Health Canada

marcan pharmaceuticals inc - pemetrexed (pemetrexed disodium hemipentahydrate) - powder for solution - 500mg - pemetrexed (pemetrexed disodium hemipentahydrate) 500mg - antineoplastic agents

Kanada - Englisch - Health Canada

mylan pharmaceuticals ulc - pemetrexed (pemetrexed disodium hemipentahydrate) - powder for solution - 500mg - pemetrexed (pemetrexed disodium hemipentahydrate) 500mg - antineoplastic agents

Europäische Union - Englisch - EMA (European Medicines Agency)

accord healthcare s.l.u. - pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed accord in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed accord in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.pemetrexed accord is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.pemetrexed accord is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.